ClinicalTrialsFinder

AML (Acute Myeloid Leukemia) Clinical Trials in Harbin, Heilongjiang

1 recruitingHarbin, Heilongjiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

AML (Acute Myeloid Leukemia)Allogeneic Hematopoietic Cell Transplantation (HCT)
Institute of Hematology & Blood Diseases Hospital, China134 enrolled5 locationsNCT07304232